Sleeping Beauty mutagenesis: Exploiting forward genetic screens for cancer gene discovery

Current Opinion in Genetics and Development

Volumn 24, Issue 1, 2014, Pages 16-22

  Mann, Michael B ^a   Jenkins, Nancy A ^a   Copeland, Neal G ^a   Mann, Karen M ^a  

^a HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SUSCEPTIBILITY; COPY NUMBER VARIATION; CPG ISLAND; DNA METHYLATION; DNA SEQUENCE; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENETIC SCREENING; HUMAN; LIVER CELL CARCINOMA; METASTASIS; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; REVIEW; SLEEPING BEAUTY MUTAGENESIS; TRANSPOSON; TUMOR GENE; TUMOR GROWTH; WNT SIGNALING PATHWAY;

ANIMALS; GENES, NEOPLASM; GENETIC TESTING; HUMANS; MODELS, GENETIC; MUTAGENESIS; NEOPLASMS; TRANSPOSASES;

EID: 84890745706     PISSN: 0959437X     EISSN: 18790380     Source Type: Journal    
DOI: 10.1016/j.gde.2013.11.004     Document Type: Review

References (36)

1. Dupuy A.J., Akagi K., Largaespada D.A., Copeland N.G., Jenkins N.A. Mammalian mutagenesis using a highly mobile somatic Sleeping Beauty transposon system. Nature 2005, 436:221-226.
2. Collier L.S., Carlson C.M., Ravimohan S., Dupuy A.J., Largaespada D.A. Cancer gene discovery in solid tumours using transposon-based somatic mutagenesis in the mouse. Nature 2005, 436:272-276.
3. Copeland N.G., Jenkins N.A. Harnessing transposons for cancer gene discovery. Nat Rev Cancer 2010, 10:696-706.
4. Dupuy A.J., Rogers L.M., Kim J., Nannapaneni K., Starr T.K., Liu P., Largaespada D.A., Scheetz T.E., Jenkins N.A., Copeland N.G. A modified Sleeping Beauty transposon system that can be used to model a wide variety of human cancers in mice. Cancer Res 2009, 69:8150-8156.
5. Starr T.K., Allaei R., Silverstein K.A., Staggs R.A., Sarver A.L., Bergemann T.L., Gupta M., O'Sullivan M.G., Matise I., Dupuy A.J., et al. A transposon-based genetic screen in mice identifies genes altered in colorectal cancer. Science 2009, 323:1747-1750.
6. Mann K.M., Jenkins N.A., Copeland N.G., Mann M.B. Transposon Insertional Mutagenesis Models of Cancer. Cold Spring Harb Protoc 2013.
7. March H.N., Rust A.G., Wright N.A., ten Hoeve J., de Ridder J., Eldridge M., van der Weyden L., Berns A., Gadiot J., Uren A., et al. Insertional mutagenesis identifies multiple networks of cooperating genes driving intestinal tumorigenesis. Nat Genet 2011, 43:1202-1209.
8. Brett B.T., Berquam-Vrieze K.E., Nannapaneni K., Huang J., Scheetz T.E., Dupuy A.J. Novel molecular and computational methods improve the accuracy of insertion site analysis in Sleeping Beauty-induced tumors. PLoS One 2011, 6:e24668.
9. Bergemann T.L., Starr T.K., Yu H., Steinbach M., Erdmann J., Chen Y., Cormier R.T., Largaespada D.A., Silverstein K.A. New methods for finding common insertion sites and co-occurring common insertion sites in transposon- and virus-based genetic screens. Nucleic Acids Res 2012, 40:3822-3833.
10. Mann K.M., Ward J.M., Yew C.C., Kovochich A., Dawson D.W., Black M.A., Brett B.T., Sheetz T.E., Dupuy A.J., Chang D.K., et al. Sleeping Beauty mutagenesis reveals cooperating mutations and pathways in pancreatic adenocarcinoma. Proc Natl Acad Sci U S A 2012, 109:5934-5941.
11. Rahrmann E.P., Watson A.L., Keng V.W., Choi K., Moriarity B.S., Beckmann D.A., Wolf N.K., Sarver A., Collins M.H., Moertel C.L., et al. Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. Nat Genet 2013, 45:756-766.
12. van der Weyden L., Rust A.G., McIntyre R.E., Robles-Espinoza C.D., del Castillo Velasco-Herrera M., Strogantsev R., Ferguson-Smith A.C., McCarthy S., Keane T.M., Arends M.J., et al. Jdp2 downregulates Trp53 transcription to promote leukaemogenesis in the context of Trp53 heterozygosity. Oncogene 2013, 32:397-402.
13. van der Weyden L., Arends M.J., Rust A.G., Poulogiannis G., McIntyre R.E., Adams D.J. Increased tumorigenesis associated with loss of the tumor suppressor gene Cadm1. Mol Cancer 2012, 11:29.
14. van der Weyden L., Papaspyropoulos A., Poulogiannis G., Rust A.G., Rashid M., Adams D.J., Arends M.J., O'Neill E. Loss of RASSF1A synergizes with deregulated RUNX2 signaling in tumorigenesis. Cancer Res 2012, 72:3817-3827.
15. Tang J.Z., Carmichael C.L., Shi W., Metcalf D., Ng A.P., Hyland C.D., Jenkins N.A., Copeland N.G., Howell V.M., Zhao Z.J., et al. Transposon mutagenesis reveals cooperation of ETS family transcription factors with signaling pathways in erythro-megakaryocytic leukemia. Proc Natl Acad Sci U S A 2013, 110:6091-6096.
16. Zanesi N., Balatti V., Riordan J., Burch A., Rizzotto L., Palamarchuk A., Cascione L., Lagana A., Dupuy A.J., Croce C.M., et al. A Sleeping Beauty screen reveals NF-kB activation in CLL mouse model. Blood 2013, 121:4355-4358.
17. Berquam-Vrieze K.E., Nannapaneni K., Brett B.T., Holmfeldt L., Ma J., Zagorodna O., Jenkins N.A., Copeland N.G., Meyerholz D.K., Knudson C.M., et al. Cell of origin strongly influences genetic selection in a mouse model of T-ALL. Blood 2011, 118:4646-4656.
18. Quintana R.M., Dupuy A.J., Bravo A., Casanova M.L., Alameda J.P., Page A., Sanchez-Viera M., Ramirez A., Navarro M. A transposon-based analysis of gene mutations related to skin cancer development. J Invest Dermatol 2013, 133:239-248.
19. Rogers L.M., Riordan J.D., Swick B.L., Meyerholz D.K., Dupuy A.J. Ectopic expression of Zmiz1 induces cutaneous squamous cell malignancies in a mouse model of cancer. J Invest Dermat 2013, 133:1863-1869.
20. Keng V.W., Sia D., Sarver A.L., Tschida B.R., Fan D., Alsinet C., Sole M., Lee W.L., Kuka T.P., Moriarity B.S., et al. Sex bias occurrence of hepatocellular carcinoma in Poly7 molecular subclass is associated with EGFR. Hepatology 2013, 57:120-130.
21. Keng V.W., Villanueva A., Chiang D.Y., Dupuy A.J., Ryan B.J., Matise I., Silverstein K.A., Sarver A., Starr T.K., Akagi K., et al. A conditional transposon-based insertional mutagenesis screen for genes associated with mouse hepatocellular carcinoma. Nat Biotechnol 2009, 27:264-274.
22. O'Donnell K.A., Keng V.W., York B., Reineke E.L., Seo D., Fan D., Silverstein K.A., Schrum C.T., Xie W.R., Mularoni L., et al. A Sleeping Beauty mutagenesis screen reveals a tumor suppressor role for Ncoa2/Src-2 in liver cancer. Proc Natl Acad Sci U S A 2012, 109:E1377-E1386.
23. Riordan J.D., Keng V.W., Tschida B.R., Scheetz T.E., Bell J.B., Podetz-Pedersen K.M., Moser C.D., Copeland N.G., Jenkins N.A., Roberts L.R., et al. Identification of rtl1, a retrotransposon-derived imprinted gene, as a novel driver of hepatocarcinogenesis. PLoS Genet 2013, 9:e1003441.
24. Perez-Mancera P.A., Rust A.G., van der Weyden L., Kristiansen G., Li A., Sarver A.L., Silverstein K.A., Grutzmann R., Aust D., Rummele P., et al. The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma. Nature 2012, 486:266-270.
25. Biankin A.V., Waddell N., Kassahn K.S., Gingras M.C., Muthuswamy L.B., Johns A.L., Miller D.K., Wilson P.J., Patch A.M., Wu J., et al. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature 2012, 491:399-405.
26. Jones S., Zhang X., Parsons D.W., Lin J.C., Leary R.J., Angenendt P., Mankoo P., Carter H., Kamiyama H., Jimeno A., et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 2008, 321:1801-1806.
27. Koso H., Takeda H., Yew C.C., Ward J.M., Nariai N., Ueno K., Nagasaki M., Watanabe S., Rust A.G., Adams D.J., et al. Transposon mutagenesis identifies genes that transform neural stem cells into glioma-initiating cells. Proc Natl Acad Sci U S A 2012, 109:E2998-E3007.
28. Wu X., Northcott P.A., Dubuc A., Dupuy A.J., Shih D.J., Witt H., Croul S., Bouffet E., Fults D.W., Eberhart C.G., et al. Clonal selection drives genetic divergence of metastatic medulloblastoma. Nature 2012, 482:529-533.
29. Mumert M., Dubuc A., Wu X., Northcott P.A., Chin S.S., Pedone C.A., Taylor M.D., Fults D.W. Functional genomics identifies drivers of medulloblastoma dissemination. Cancer Res 2012, 72:4944-4953.
30. Keng V.W., Ryan B.J., Wangensteen K.J., Balciunas D., Schmedt C., Ekker S.C., Largaespada D.A. Efficient transposition of Tol2 in the mouse germline. Genetics 2009, 183:1565-1573.
31. Ivics Z., Hackett P.B., Plasterk R.H., Izsvak Z. Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells. Cell 1997, 91:501-510.
32. Landrette S.F., Cornett J.C., Ni T.K., Bosenberg M.W. Xu T: piggyBac transposon somatic mutagenesis with an activated reporter and tracker (PB-SMART) for genetic screens in mice. PLoS One 2011, 6:e26650.
33. Rad R., Rad L., Wang W., Cadinanos J., Vassiliou G., Rice S., Campos L.S., Yusa K., Banerjee R., Li M.A., et al. PiggyBac transposon mutagenesis: a tool for cancer gene discovery in mice. Science 2010, 330:1104-1107.
34. de Ridder J., Uren A., Kool J., Reinders M., Wessels L. Detecting statistically significant common insertion sites in retroviral insertional mutagenesis screens. PLoS Comput Biol 2006, 2:e166.
35. Sarver A.L., Erdman J., Starr T., Largaespada D.A., Silverstein K.A. TAPDANCE: an automated tool to identify and annotate transposon insertion CISs and associations between CISs from next generation sequence data. BMC Bioinform 2012, 13:154.
36. Rogers L.M., Olivier A.K., Meyerholz D.K., Dupuy A.J. Adaptive immunity does not strongly suppress spontaneous tumors in a Sleeping Beauty model of cancer. J Immunol 2013, 190:4393-4399.